Phibro Animal Health Corporation
PAHC
$43.37
$1.313.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.30B | 1.19B | 1.11B | 1.05B | 1.02B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.30B | 1.19B | 1.11B | 1.05B | 1.02B |
| Cost of Revenue | 890.59M | 806.46M | 752.12M | 717.38M | 704.07M |
| Gross Profit | 405.62M | 384.23M | 353.96M | 329.38M | 313.61M |
| SG&A Expenses | 269.68M | 262.10M | 251.07M | 241.01M | 247.09M |
| Depreciation & Amortization | 2.38M | 2.99M | 2.99M | 2.99M | 2.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16B | 1.07B | 1.01B | 961.37M | 954.14M |
| Operating Income | 133.56M | 119.14M | 99.90M | 85.39M | 63.54M |
| Income Before Tax | 67.99M | 50.55M | 33.79M | 32.52M | 10.92M |
| Income Tax Expenses | 19.73M | 18.76M | 14.47M | 15.11M | 8.50M |
| Earnings from Continuing Operations | 48.26 | 31.79 | 19.32 | 17.41 | 2.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.26M | 31.79M | 19.32M | 17.41M | 2.42M |
| EBIT | 133.56M | 119.14M | 99.90M | 85.39M | 63.54M |
| EBITDA | 177.75M | 160.10M | 137.44M | 120.27M | 98.28M |
| EPS Basic | 1.19 | 0.78 | 0.48 | 0.43 | 0.06 |
| Normalized Basic EPS | 1.41 | 1.15 | 0.80 | 0.71 | 0.33 |
| EPS Diluted | 1.18 | 0.78 | 0.47 | 0.43 | 0.06 |
| Normalized Diluted EPS | 1.40 | 1.15 | 0.80 | 0.71 | 0.33 |
| Average Basic Shares Outstanding | 162.03M | 162.03M | 162.01M | 162.01M | 162.01M |
| Average Diluted Shares Outstanding | 162.71M | 162.61M | 162.42M | 162.21M | 162.13M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 40.30% | 61.17% | 100.64% | 111.70% | 804.72% |